The agenda has been set for the June 22 ASCO/Food and Drug Administration (FDA) “Core Outcome Assessments in Cancer Clinical Trials” workshop.
ASCO in Action regularly provides the latest news and analysis related to cancer policy news; see the following online articles. These updates provide snapshots of ASCO’s ongoing advocacy efforts, as well as opportunities for ASCO members and guests to take action on critical issues affecting the cancer community.
To sign up for advocacy alerts, log in to ASCO.org with your ASCO member or guest account, and visit the subscription center available under your account profile.
ASCO joined nearly 50 medical organizations in urging the Centers for Medicare & Medicaid Services (CMS) to reduce the quality performance period under the 2018 Merit-based Incentive Payment System (MIPS) to 90 days instead of a full calendar year.
Last week, members of PracticeNET came together for their biannual networking meeting, where participants reviewed benchmarking data and preliminary results from the 2018 Survey of Oncology Practice Operations, and received updates on new initiatives, including ASCO’s new practice website, ASCO Practice Central.
Applications for the Alexandria, Va. session of ASCO’s Quality Training Program, being held at ASCO headquarters, are being accepted now through June 4.
Linda D. Bosserman, MD, FACP, FASCO, has been named Editor-in-Chief of the Journal of Oncology Practice (JOP), a publication of ASCO. Dr. Bosserman is a recognized leader in cancer care delivery with a deep understanding of the issues impacting all types of oncology practices.
ASCO is launching ASCO Practice Central, a new website that serves as an online information hub to help oncology professionals navigate a complicated and ever-changing practice environment—while providing high-quality patient care. The first ASCO website dedicated to the business of oncology, ASCO Practice Central provides a one-stop, centralized resource that oncology practices can use to address a wide range of practical issues, including changes to physician reimbursement, quality reporting requirements, and business management practices.
March 4, 2018, is International HPV Awareness Day, which aims to promote education about human papillomavirus (HPV), raise awareness about prevention methods, and encourage governments and individuals to take advantage of the HPV vaccine and screening for cancer.
On Feb. 16, 2018, JCO Clinical Cancer Informatics (JCO CCI) published its first special collection of articles. This collection highlights ways in which sharing cancer research data is now possible through individual networks, including ASCO’s CancerLinQ®.
Biosimilars have rapidly proliferated in the cancer care landscape, leaving many providers unclear about the full impact these products will have on the care they deliver to patients. “American Society of Clinical Oncology Statement: Biosimilars in Oncology,” published in the Journal of Clinical Oncology, examines a range of issues to help ASCO members better understand the impact of biosimilars on oncology care.
ASCO provided comments to the Federation of State Medical Boards (FSMB) on a proposed position statement entitled “Compounding of Medications by Physicians.” The society appreciates FSMB’s efforts to ensure the safety of compounded medications, but believes that if finalized in its current form, the FSMB’s position statement would lead to confusion among cancer care providers and create barriers to providing chemotherapy to patients with cancer. ASCO urges FSMB to make clarifications and specific edits to the proposal, or to delay final approval of the position statement to allow time for refinements.
Clinica AMO has become the second practice in Brazil to receive Quality Oncology Practice Initiative (QOPI®) certification through QOPI Certification Program, LLC, and the sixth practice internationally to receive this accreditation.